Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
Open Access
- 1 September 1995
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 182 (3) , 885-889
- https://doi.org/10.1084/jem.182.3.885
Abstract
Vaccination of mice with heat shock proteins isolated from tumor cells induces immunity to subsequent challenge with those tumor cells the heat shock protein was isolated from but not with other tumor cells (Udono, H., and P.K. Srivastava. 1994. J. Immunol. 152:5398-5403). The specificity of this immune response is caused by tumor-derived peptides bound to the heat shock proteins (Udono., H., and P.K. Srivastava. 1993. J. Exp. Med. 178:1391-1396). Our experiments show that a single immunization with the heat shock protein gp96 isolated from beta-galactosidase (beta-gal) expressing P815 cells (of DBA/2 origin) induces cytotoxic T lymphocytes (CTLs) specific for beta-gal, in addition to minor H antigens expressed by these cells. CTLs can be induced in mice that are major histocompatibility complex (MHC) identical to the gp96 donor cells (H-2d) as well as in mice with a different MHC (H-2b). Thus gp96 is able to induce "cross priming" (Matzinger, P., and M.J. Bevan. 1977. Cell. Immunol. 33:92-100), indicating that gp96-associated peptides are not limited to the MHC class I ligands of the gp96 donor cell. Our data confirm the notion that samples of all cellular antigens presentable by MHC class I molecules are represented by peptides associated with gp96 molecules of that cell, even if the fitting MHC molecule is not expressed. In addition, we extend previous reports on the in vivo immunogenicity of peptides associated gp96 molecules to two new groups of antigens, minor H antigens, and proteins expressed in the cytosol.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.The Journal of Immunology, 1994
- Peptide size selection by the major histocompatibility complex-encoded peptide transporter.The Journal of Experimental Medicine, 1994
- Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.Proceedings of the National Academy of Sciences, 1994
- Heat Shock Protein Vaccines Against CancerJournal of Immunotherapy, 1993
- Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.The Journal of Immunology, 1993
- Heat shock protein 70-associated peptides elicit specific cancer immunity.The Journal of Experimental Medicine, 1993
- Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.1993
- Peptides Naturally Presented by MHC Class I MoleculesAnnual Review of Immunology, 1993
- Proteasomes are regulated by interferon gamma: implications for antigen processing.Proceedings of the National Academy of Sciences, 1992
- Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.The Journal of Experimental Medicine, 1991